|
| |
| | | 65041 | | 12.09.2014 | | Novo Nordisk Pharma AG | | | | | | | | | | | | | 07.06.10. | | | | 07.06. | | IPro |
| | Seq.-nr. | Préparation | Description | Forme galénique | Classe d'ATC | |
|---|
| 01 | Xultophy Insulin Degludec 100 E/ml und Liraglutide 3.6 mg/ml | Injektionslösung | Solution injectable (Insulinum Degludecum 600 , Nmol 0 , Liraglutidum 3.6 mg/ml) | A10AE56 | IPat |
|
|
|
